Literature DB >> 11181386

High-dose intravenous ribavirin therapy for subacute sclerosing panencephalitis.

M Hosoya1, S Shigeta, S Mori, A Tomoda, S Shiraishi, T Miike, H Suzuki.   

Abstract

Two patients with subacute sclerosing panencephalitis (SSPE) were treated safely and effectively with high doses of intravenous ribavirin combined with intraventricular alpha interferon. The ribavirin concentrations maintained in the serum and cerebrospinal fluid were higher than those which inhibit SSPE virus replication in vitro and in vivo.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11181386      PMCID： PMC90399          DOI： 10.1128/AAC.45.3.943-945.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  13 in total

1.  Inhibitory effect of selected antiviral compounds on measles (SSPE) virus replication in vitro.

Authors:  M Hosoya; S Shigeta; K Nakamura; E De Clercq
Journal:  Antiviral Res       Date:  1989-09       Impact factor: 5.970

2.  Oral ribavirin therapy for subacute sclerosing panencephalitis.

Authors:  J W Ogle; P Toltzis; W D Parker; N Alvarez; K McIntosh; M J Levin; B A Lauer
Journal:  J Infect Dis       Date:  1989-04       Impact factor: 5.226

3.  The cooperative effect of interferon-alpha and ribavirin on subacute sclerosing panencephalitis (SSPE) virus infections, in vitro and in vivo.

Authors:  T Takahashi; M Hosoya; K Kimura; K Ohno; S Mori; K Takahashi; S Shigeta
Journal:  Antiviral Res       Date:  1998-01       Impact factor: 5.970

4.  Combined treatment with interferon-alpha and ribavirin for subacute sclerosing panencephalitis.

Authors:  A Tomoda; S Shiraishi; M Hosoya; A Hamada; T Miike
Journal:  Pediatr Neurol       Date:  2001-01       Impact factor: 3.372

5.  Effect of ribavirin on subacute sclerosing panencephalitis virus infections in hamsters.

Authors:  Y Honda; M Hosoya; T Ishii; S Shigeta; H Suzuki
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

6.  Ribavirin response in measles pneumonia.

Authors:  S Gururangan; R F Stevens; D J Morris
Journal:  J Infect       Date:  1990-05       Impact factor: 6.072

Review 7.  Subacute measles encephalitis in the young immunocompromised host: report of two cases diagnosed by polymerase chain reaction and treated with ribavirin and review of the literature.

Authors:  M M Mustafa; S D Weitman; N J Winick; W J Bellini; C F Timmons; J D Siegel
Journal:  Clin Infect Dis       Date:  1993-05       Impact factor: 9.079

8.  Ribavirin disposition in high-risk patients for acquired immunodeficiency syndrome.

Authors:  O L Laskin; J A Longstreth; C C Hart; D Scavuzzo; C M Kalman; J D Connor; R B Roberts
Journal:  Clin Pharmacol Ther       Date:  1987-05       Impact factor: 6.875

9.  In vitro effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on deoxyribonucleic acid and ribonucleic acid viruses.

Authors:  J H Huffman; R W Sidwell; G P Khare; J T Witkowski; L B Allen; R K Robins
Journal:  Antimicrob Agents Chemother       Date:  1973-02       Impact factor: 5.191

10.  Severe measles pneumonitis in adults: evaluation of clinical characteristics and therapy with intravenous ribavirin.

Authors:  A L Forni; N W Schluger; R B Roberts
Journal:  Clin Infect Dis       Date:  1994-09       Impact factor: 9.079
View more
  11 in total

Review 1.  Subacute sclerosing panencephalitis.

Authors:  R K Garg
Journal:  Postgrad Med J       Date:  2002-02       Impact factor: 2.401

2.  The time-course of ribavirin-provoked changes of basal and AMPH-induced motor activities in rats.

Authors:  Branka Janać; Vesna Pesić; Sanja Peković; Ljubisav Rakić; Mirjana Stojiljković
Journal:  Exp Brain Res       Date:  2005-05-10       Impact factor: 1.972

3.  Pharmacokinetics and effects of ribavirin following intraventricular administration for treatment of subacute sclerosing panencephalitis.

Authors:  Mitsuaki Hosoya; Shuichi Mori; Akemi Tomoda; Kenji Mori; Yukio Sawaishi; Hiroshi Kimura; Shiro Shigeta; Hitoshi Suzuki
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

4.  Subacute Sclerosing Panencephalitis in Children: The Archetype of Non-Vaccination.

Authors:  Laura Papetti; Maria Elisa Amodeo; Letizia Sabatini; Melissa Baggieri; Alessandro Capuano; Federica Graziola; Antonella Marchi; Paola Bucci; Emilio D'Ugo; Maedeh Kojouri; Silvia Gioacchini; Carlo Efisio Marras; Carlotta Ginevra Nucci; Fabiana Ursitti; Giorgia Sforza; Michela Ada Noris Ferilli; Gabriele Monte; Romina Moavero; Federico Vigevano; Massimiliano Valeriani; Fabio Magurano
Journal:  Viruses       Date:  2022-03-31       Impact factor: 5.818

Review 5.  Healthcare-associated exposure to Borna disease virus 1 (BoDV-1).

Authors:  Judith Reinmiedl; Heiko Schulz; Viktoria C Ruf; Moritz R Hernandez Petzsche; Jürgen Rissland; Dennis Tappe
Journal:  J Occup Med Toxicol       Date:  2022-06-09       Impact factor: 2.862

Review 6.  Enterovirus infections of the central nervous system.

Authors:  Ross E Rhoades; Jenna M Tabor-Godwin; Ginger Tsueng; Ralph Feuer
Journal:  Virology       Date:  2011-01-20       Impact factor: 3.616

Review 7.  Advances in Antiviral Therapy for Subacute Sclerosing Panencephalitis.

Authors:  Koichi Hashimoto; Mitsuaki Hosoya
Journal:  Molecules       Date:  2021-01-15       Impact factor: 4.411

8.  A Novel Peptide Derived from the Fusion Protein Heptad Repeat Inhibits Replication of Subacute Sclerosing Panencephalitis Virus In Vitro and In Vivo.

Authors:  Masahiro Watanabe; Koichi Hashimoto; Yusaku Abe; Eiichi N Kodama; Ryota Nabika; Shinya Oishi; Shinichiro Ohara; Masatoki Sato; Yukihiko Kawasaki; Nobutaka Fujii; Mitsuaki Hosoya
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

Review 9.  Organization, Function, and Therapeutic Targeting of the Morbillivirus RNA-Dependent RNA Polymerase Complex.

Authors:  Julien Sourimant; Richard K Plemper
Journal:  Viruses       Date:  2016-09-10       Impact factor: 5.048

10.  Ribavirin as a potential therapeutic for atypical teratoid/rhabdoid tumors.

Authors:  Betty Tyler; Nicolas Skuli; Joshua Casaos; Sakibul Huq; Tarik Lott; Raphael Felder; John Choi; Noah Gorelick; Michael Peters; Yuanxuan Xia; Russell Maxwell; Tianna Zhao; Chenchen Ji; Thomas Simon; Julie Sesen; Sarah J Scotland; Richard E Kast; Jeffrey Rubens; Eric Raabe; Charles G Eberhart; Eric M Jackson; Henry Brem
Journal:  Oncotarget       Date:  2018-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.